Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A – CNW GroupMONTREAL, Jan. 17 /CNW Telbec/ – Immunotec Inc. (TSX-V: IMM) announced today the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients which was performed in Immunotec Inc. – Health Canada Approves Health Claim…